BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29232285)

  • 1. Cyclophosphamide-Induced Hearing Loss: Reversibility and Preventive Strategies.
    Tuknayat A; Thami GP; Gogia P; Bhutani M
    Am J Ther; 2018; 25(6):e692-e695. PubMed ID: 29232285
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term efficacy of dexamethasone-cyclophosphamide pulse therapy in pemphigus.
    Kanwar AJ; Kaur S; Thami GP
    Dermatology; 2002; 204(3):228-31. PubMed ID: 12037452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of pulse therapy in 74 patients with pemphigus.
    Roga G; Augustine M
    Indian J Dermatol Venereol Leprol; 2018; 84(3):331-333. PubMed ID: 29600798
    [No Abstract]   [Full Text] [Related]  

  • 4. Dexamethasone-cyclophosphamide pulse therapy in pemphigus: a review of 72 cases.
    Zivanovic D; Medenica L; Tanasilovic S; Vesic S; Skiljevic D; Tomovic M; Nikolic MM
    Am J Clin Dermatol; 2010; 11(2):123-9. PubMed ID: 20141233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone-cyclophosphamide pulse therapy in pemphigus.
    Manzoor S; Bhat Y; Ahmad S; ;
    Indian J Dermatol Venereol Leprol; 2009; 75(2):184-6. PubMed ID: 19293511
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolonged remission of pemphigus induced by dexamethasone-cyclophosphamide pulse therapy.
    Gupta R
    Indian J Dermatol Venereol Leprol; 2007; 73(2):121-2. PubMed ID: 17456923
    [No Abstract]   [Full Text] [Related]  

  • 7. Immediate and delayed complications of dexamethasone cyclophosphamide pulse (DCP) therapy.
    Jain R; Kumar B
    J Dermatol; 2003 Oct; 30(10):713-8. PubMed ID: 14684952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting the duration of phase I of dexamethasone - cyclophosphamide pulse therapy.
    Nayak CS; Ray S; Thombre A; Jain M
    Indian J Dermatol Venereol Leprol; 2014; 80(4):296-9. PubMed ID: 25035352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the therapeutic benefit of dexamethasone cyclophosphamide pulse versus only oral cyclophosphamide in phase II of the dexamethasone cyclophosphamide pulse therapy: a preliminary prospective randomized controlled study.
    Parmar NV; Kanwar AJ; Minz RW; Parsad D; Vinay K; Tsuruta D; Ishii N; Hashimoto T
    Indian J Dermatol Venereol Leprol; 2013; 79(1):70-6. PubMed ID: 23254732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse therapy in pemphigus: report of 11 cases.
    Fernandes NC; Menezes M
    An Bras Dermatol; 2013; 88(4):672-5. PubMed ID: 24068153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of idiopathic sudden sensorineural hearing loss using pulse therapy: a prospective, randomized, double-blind clinical trial.
    Westerlaken BO; de Kleine E; van der Laan B; Albers F
    Laryngoscope; 2007 Apr; 117(4):684-90. PubMed ID: 17415139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of oral cyclophosphamide with dexamethasone pulse therapy in the treatment of pemphigus vulgaris.
    Momeni AZ; Iraji F; Aminjavaheri M; Emami MR; Momeni A
    J Dermatolog Treat; 2007; 18(5):275-8. PubMed ID: 17852639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized open comparative trial of dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris.
    Sethy PK; Khandpur S; Sharma VK
    Indian J Dermatol Venereol Leprol; 2009; 75(5):476-82. PubMed ID: 19736426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of dexamethasone-cyclophosphamide pulse therapy in pemphigus: a case series.
    Kandan S; Thappa DM
    Indian J Dermatol Venereol Leprol; 2009; 75(4):373-8. PubMed ID: 19584462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemphigus in North-Western Yemen: A therapeutic study of 75 cases.
    Khatri ML
    Indian J Dermatol Venereol Leprol; 2016; 82(3):359. PubMed ID: 27088959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of corticosteroid pulse therapy: a prospective controlled study on pemphigus patients.
    Jain R; Bali H; Sharma VK; Kumar B
    Int J Dermatol; 2005 Apr; 44(4):285-8. PubMed ID: 15811078
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dexamethasone-cyclophosphamide pulse therapy in bullous autoimmune dermatoses].
    Appelhans M; Bonsmann G; Orge C; Bröcker EB
    Hautarzt; 1993 Mar; 44(3):143-7. PubMed ID: 8463094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Weekly cyclophosphamide pulse therapy combined with corticosteroids in the treatment of pemphigus].
    Jia GQ; Chen ZQ; Li HL; Cui PG; Xu WY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Apr; 23(2):173-5. PubMed ID: 12905897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone-cyclophosphamide pulse therapy in pemphigus.
    Kaur S; Kanwar AJ
    Int J Dermatol; 1990 Jun; 29(5):371-4. PubMed ID: 2361797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hiccup--a side-effect of pulse therapy.
    Kanwar AJ; Kaur S; Dhar S; Ghosh S
    Dermatology; 1993; 187(4):279. PubMed ID: 8274787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.